| Lightcalls.com |
|
|
![]() |
A celebrated comedian, the late Geo...A celebrated comedian, the late George chars was once asked if he had at any time had arthritis. "Have I had arthritis? I got it when it first came out!" His answer was funny, but far from historically accurate. Arthritis may walk way back, but it's more prevalent now Archaeologists who make it their business to dig up and study artifacts and bone from ancient civilizations count us there's strong evidence that the prehistoric Neanderthal man of 40000 to 100000 years ago stomached from arthritis. Nevertheless, the nutritional stripmining practiced from most of the mass-market mainstream food-processors has helped bring on industrialized society's "arthritis epidemic." Inasmuch as arthritis goe in like manner far back, it is about time that researchers originate ways to cope with the pain, inflammation, and restricted motion typical of osteoarthritis and rheumatoid arthritis, the two most widespread types A focus upon treating the pain symptoms alone This is greatest in quantity welcome news, because foundations funding studies for coping with arthritis have been defeatist. Their stance has been, "You can't restorative it. You can only deaden its pain." And "deaden" they did with all sorts of non-steroidal anti-inflammatory drug (NSAIDs), the side-effects of which were usually almost as unpleasant, painful, and damaging as the symptoms of arthritis: nausea, vomiting, stomach ulcers gastrointestinal bleeding, abdominal pain, fluid retention, allergic reactions, and liver and/or kidney damage. Arthritis -- the stats and the facts Various statisticians state that anywhere from 16 million to 37 million Americans, alone, have osteoarthritis or rheumatoid arthritis. Osteoarthritis is a painful grinding of joint bone against one another, principally often in the shoulder, arm, or knee This come to passs when cartilage, a form of gristly insulation, has worn away. Also, sometimes the synovial tissues thicken and no longer act as a cushion. most numerous likely candidates for osteoarthritis are obese and other abnormally heavy the bulk of mankind frequent participants in contact sports, marathon racers mail deliverers, weight-lifters, sandhogs, and stevedores. Usually it happens in persons after age 50 (See sidebar forward p. 34 on osteoarthritis' risk factors.) In rheumatoid arthritis, the immune rule mistakes its own tissue as an enemy and attacks it, causing brutish joint pain (often of the symmetric joints -- knee thumbs elbow hips, etc) inflammation, swelling, and stiffness. This rheumatoid form is a often more systemic disease, often involving the entire corpse For example, sufferers are oftentimes tired, lose weight, and tolerate from anemia. While this is an autoinimune disease, it is exacerbated by means of cumulative insults from various sources: digestive imbalances, malnutrition, high-fat diets, bread and environmental chemicals, stress, fodder and environmental sensitivities, allergies, and adrenal exhaustion. Grossly unfair, on the contrary true, is the fact that three times more women than men lay open rheumatoid arthritis. Unlike osteoarthritis, doesn't wait until middle age to attack. It strikes population as young 20. Often triggered at biochemical and emotional stress, rheumatoid arthritis sometimes attacks young women right after they deliver a baby. Other major forms of arthritis include: ankylosing spondylitis, gout Lyme arthritis, and systemic lupus erythematosus. Pain, limited emotion and depression Pain and stiffness characteristic of one as well as the other kinds of arthritis limit range of motion, lower morale, and may even bring upon depression. single in kind natural treatment that seems to help with the one and the other kinds of arthritis is yucca, a folk medicine used for more than 1000 years according to Native Americans. Double-blind studies with yucca manner of lifeed by Robert Bingham, M.D., of the National Arthritis Medical Center in Desert Hot Springs, Calif., showed dramatic results above 12 months, 67 rheumatoid and 97 osteoarthritis sufferer were divided into sum of two units groups, both continuing their prescribed medication. One form into groups received a 300-mg tablet of yucca daily. The other group was given a look-alike placebo tablet. More than 60 percent of the yucca takers reported gradual relief from swelling, stiffness, and pain, plus unanticipated benefits: improved blood circulation, clearer skin, healthier hair, relief from headaches, and a significant ear-ring in blood pressure, cholesterol, and triglycerides. A strange understanding emerges More is coming public of late, about the link between oxidative stres -- excess free radicals and insufficient free-radical-scavenging nutrients -- and arthritis. In the British Medical Bulletin (1995) P.I. Mapp, and colleagues, published a reflection they conducted which showed that, in rheumatoid arthritis, for example, damage to the joint cavity which houses the synovial fluid is related to overproduction of liberated radicals and an absence of a adapted antioxidant defense. A 1996 application of mind by M. Sato, and colleagues (Journal of Rheumatology), suggest that n-acetyl-cysteine (NAC), glutathione sulf hydryl (GSH) and catalase work together to block up the inflammatory processes that be derived in excess levels of |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |